Obesity is associated with cardiac insulin resistance and contractile dysfunction that contribute to the 27 development of heart failure. The RhoA-ROCK pathway has been reported to modulate insulin 28 resistance, but whether it is implicated in obesity-induced cardiac dysfunction is not known. To test 29 this, wild-type (WT) and ROCK2+/-mice were fed normal chow or a high fat diet (HFD) for 17 weeks. 30 HFD-WT mice exhibited whole body insulin resistance, determined by an insulin tolerance test, but 31 this was not seen in HFD-ROCK2+/-mice. The echocardiographically-determined myocardial 32 performance index (MPI), a measure of global systolic and diastolic function, was significantly 33 increased in HFD-WT mice, indicating a deterioration in cardiac function. However, no change in MPI 34 was found in hearts from HFD-ROCK2+/-mice. Speckle tracking-based strain echocardiography also 35 revealed regional impairment in left ventricular wall motion in hearts from HFD-WT but not HFD-36 ROCK2+/-mice. The activity of both ROCK1 and ROCK2 was significantly increased in HFD-WT 37 hearts, and GLUT4 expression was significantly reduced. Insulin-induced phosphorylation of IRS 38 Tyr 612 , Akt, and AS160 were also impaired in these hearts, while phosphorylation of IRS Ser 307 was 39 increased. In contrast, the increase in ROCK2 but not ROCK1 activity was prevented in hearts from 40 HFD-ROCK2+/-mice, and cardiac levels of TNFα were reduced. This was associated with 41 normalization of IRS phosphorylation, downstream insulin signaling and GLUT4 expression. These 42 data suggest that increased activation of ROCK2 contributes to obesity-induced cardiac dysfunction 43 and insulin resistance, and that inhibition of ROCK2 may constitute a novel approach to treat this 44 condition. 45 46 47
Introduction 50
Obesity, which is rapidly increasing in prevalence, is associated with an increased risk of 51 cardiovascular morbidity and mortality (18) . This is in part due to an increased incidence of 52 atherosclerosis and hypertension in obese individuals, but even in the absence of these conditions an 53 obesity-associated cardiomyopathy may develop, contributing to the eventual development of heart 54 failure (45) . Whether this is due to a direct adverse effect of obesity on the heart, or is secondary to 55 obesity-induced systemic insulin resistance, glucose intolerance and inflammation is not completely 56 clear (1, 2). However, many studies have shown that obesity is associated with changes in cardiac 57 insulin signaling, energy metabolism, oxidative stress and mitochondrial dysfunction that contribute to 58 the eventual impairment of contractile function (2, 8, 22, 29, 31) . 59
Rho kinase (ROCK) is a serine/threonine protein kinase activated by the small GTP binding protein 60
RhoA. Two isoforms of ROCK, known as ROCK1 and ROCK2, have been identified, both of which 61 are widely expressed (38) . Over-activation of the RhoA-ROCK pathway has been implicated in the 62 development of many forms of cardiovascular disease, including hypertension, heart failure and 63 diabetic cardiomyopathy (26). Increased ROCK activity has also been detected in the heart and other 64 tissues from obese, insulin-resistant animal models (25) and in leukocytes from patients with metabolic 65 syndrome (27). However, whether it contributes to obesity-induced changes in cardiac insulin 66 sensitivity and contractile function is not yet clear. 67
Under normal physiological conditions insulin promotes auto-phosphorylation of the insulin receptor in 68 the heart as in other insulin-sensitive tissues, leading to tyrosine phosphorylation and activation of 69 insulin receptor substrate-1 (IRS-1). IRS-1 then recruits and stimulates phosphatidylinositol 3-kinase 70 (PI3K), triggering a cascade of signaling events that lead to activation of Akt and its multiple 71 downstream targets (7) . The pathway is also subject to modulation by phosphorylation of serine 72 residues in IRS-1, which alter tyrosine phosphorylation of IRS and its interaction with PI3K (12) . 73
Insulin resistance in the heart is associated with impaired insulin receptor-induced activation of this 74 pathway (22, 31) . 75
The RhoA-ROCK pathway has been reported to regulate insulin sensitivity, but the effects of ROCK 76 activation on insulin signaling appear to be both isoform-dependent and tissue-specific. For instance, 77 ROCK 1 is required for normal insulin sensitivity in mice, since it's deletion was associated with 78 reduced tyrosine phosphorylation of IRS and impaired glucose transport in skeletal muscle (21) . 79
However, recently ROCK1 was also shown to negatively regulate insulin signaling in adipose tissue 80 (23). On the other hand, ROCK2 has been implicated in reduced insulin signaling in cultured mouse 81 embryonic fibroblasts (30) and vascular cells (5), by promoting insulin-induced phosphorylation of 82 serine residues in IRS-1. Based on the latter observations, we hypothesized that increased activation of 83 ROCK2 may contribute to impaired cardiac insulin signaling and contractile dysfunction in the setting 84 of obesity. This was investigated in the present study in ROCK2+/-and wild type (WT) mice fed a high 85 fat diet (HFD) for 17 weeks. We found that high fat feeding resulted in an increase in the activity of 86 both ROCK1 and ROCK2 in the WT mouse heart, and that this was associated with impaired cardiac 87 insulin signaling and with the development of cardiac contractile dysfunction. Furthermore, partial 88 deletion of ROCK2 not only improved whole body insulin sensitivity, but also prevented the increase 89 in cardiac ROCK2 but not ROCK1 activity and improved both cardiac insulin signaling and cardiac 90 function in obese mice. Animals. ROCK2+/-mice were generated as described in (50), and were backcrossed for 6 generations 98 on a CD-1 background. Complete ROCK2 knockout is highly embryonically lethal due to thrombus 99 formation and placental dysfunction (44) and only ROCK2+/-mice were obtained. Starting from 6 100 weeks of age, ROCK2+/-mice and WT littermates were fed either normal chow or a high fat diet (60% 101 kcal fat, Research diets Inc.) for 17 weeks. All animals were housed under identical conditions and 102 were given free access to food and water during this time. Sixteen weeks after beginning the HFD, 103 cardiac function was assessed in all mice by echocardiography, and one week later, an insulin tolerance 104 test (ITT) was performed in all animals. Three days later, mice were fasted for 5-6 hours and then 105 injected intraperitoneally with human insulin (Humulin R ® , Eli Lilly, ON, Canada; 10 units/kg), then 5 106 minutes later, deeply anesthetized with 4% isoflurane. Five minutes later mice were euthanized by 107 cervical dislocation. Hearts were then rapidly removed, weighed and the apex was fixed in 10% 108
formalin. The remainder of the heart was snap frozen in liquid nitrogen and stored at -80°C for later 109 biochemical analysis. This investigation conforms to the Canadian Council on Animal Care Guidelines 110 on the Care and Use of Experimental Animals, and the Guide for Care and Use of Laboratory Animals 111 published by the United States National Institutes of Health (NIH publication no. 85-23, revised 1996 Echocardiography and Speckle tracking analysis. Transthoracic echocardiography of the left 119 ventricle was performed as described in (9) using the Vevo ® 2100 echocardiography system (Fujifilm 120 Visualsonics, ON, Canada). Anesthesia was induced with 4 % isoflurane and then was maintained with 121 1-1.5 % isoflurane. Mice were placed on a heating pad and body temperature was maintained at 122 37±0.5°C. M-mode and 2-D parasternal short-and long-axis scans were made to assess changes in left 123 ventricle dimensions, fractional shortening, ejection fraction and cardiac output. An apical four-124 chamber view of the left ventricle was obtained, and using pulsed wave Doppler, the early (E) to late 125 transmitral velocities (E/A) ratio, isovolumic contraction and relaxation times (IVCT and IVRT, 126 respectively), and myocardial performance index (MPI) were determined. Endocardial radial and 127 longitudinal forward and reverse velocities, strain and strain rates were determined using Speckle 128 tracking with Vevostrain Immunoprecipitated pellets were collected by centrifugation at 1000 xg for 30 seconds at 4°C. The 135 pellets were washed 3 times with PBS, repeating the centrifugation step after each wash. After the last 136 wash, the supernatant was discarded and the pellet was resuspended in ROCK activity assay reaction 137 buffer (25 mM Tris HCl, pH=7.5, 10 mM MgCl 2 , 5 mM glycerol-2-phosphate) containing 500 µM 138 ATP, 500 ng recombinant MYPT1 and 1mM freshly prepared DTT and incubated for 30 139 minutes at 30°C. Recombinant ROCK2 was used as a positive control. After the 30 minutes, the 140 reaction was stopped by addition of Laemmli buffer and heating to 90°C for 5 minutes. The extent of 141
Thr-696 phosphorylation of recombinant MYPT1 was determined using SDS-PAGE followed by 142 western blot using anti-Thr 696 pMYPT1 antibody (Santa Cruz Biotechnology Inc, CA, USA) and was 143 taken as an index of ROCK isoform activity. 144
Measurement of serum non-esterified fatty acids (NEFA). Serum NEFA were estimated using a 145 commercially available kit (Zen-Bio Inc, NC, USA). 146
Measurement of serum cholesterol. Serum cholesterol was measured using a commercially available 147 kit (Pointe Scientific, MI, USA). 148
Measurement of cardiac triglycerides. Triglycerides in cardiac tissue were determined as described 149
by Le Guezennec et al. (20) . Briefly, heart tissue was homogenized in 5% NP-40 solution and heated 150 for 5 minutes at 90°C. After cooling down, the heating step was repeated and any insoluble material 151 was removed by centrifugation at 13000 rpm for 2 minutes. Triglycerides were measured in the 152 supernatant using a commercially available kit (Pointe Scientific, MI, USA) according to the 153 instructions of the manufacturer. 154
Measurement of cardiac PTEN activity. Cardiac PTEN activity was determined as described by 155 Patsoukis et al. (33) . Briefly, PTEN was immunoprecipitated from equal quantities of heart 156 homogenates by incubation with anti-PTEN-sepharose beads conjugate (Cell Signaling, MA, USA) 157 overnight at 4°C with rotation. Samples were then microcentrifuged for 30 seconds at 4°C and washed 158 5 times with lysis buffer (25 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 1mM EDTA, 5% Glycerol). 159
After the last wash, the pellets were collected by centrifugation and PTEN activity was determined 160 using the malachite green assay kit (Echelon Biosciences Inc, UT, USA) with PI(3,4,5)P 3 diC 16 161 (Echelon Biosciences Inc, UT, USA) as substrate. 162
Association of IRS with p85-PI3K. The amount of p85-PI3K co-immunoprecipitated with IRS was 163 determined by incubating equal quantities of heart homogenates with anti-IRS antibody (Cell signaling, 164 MA, USA) overnight at 4°C with continuous rotation followed by addition of 20 µL/sample of 165 resuspended protein A/G-agarose conjugate (Santa Cruz Biotechnology Inc, CA, USA) for 1 hour. 166
Immunoprecipitated pellets were collected by centrifugation at 1000 xg for 5 minutes at 4°C and 167 washed 3 times with RIPA buffer. After addition of Laemmli buffer, samples were heated at 90°C for 5 168 minutes and the levels of total IRS and p85-PI3K were determined by SDS-PAGE followed by western 169
blot. 170
Western blot. Frozen hearts were homogenized in RIPA buffer. Proteins from each sample were 171 separated by 8-12% SDS-PAGE and immunoblotted using primary antibodies against ROCK1, 172 ROCK2, RhoA, GLUT4, MYPT1 and Statistics. All values are expressed as means ± SE; n denotes the number of animals in each group. 192
Results were analyzed for statistical significance using GraphPad Prism version 5.00 for Windows 193 (GraphPad Software, San Diego, CA, USA). The ITT was analyzed by two-way repeated measures 194 ANOVA followed by the Bonferroni test. All other results were analyzed by one-way ANOVA 195 followed by the Neuman-Keul's test. Results were considered statistically significant at p<0. 05. 196 197
Results

198
Characteristics of mice 199
Prior to beginning the HFD, no differences were seen between WT and ROCK2+/-mice in terms of 200 body weight or fasting blood glucose levels. However, ROCK2+/-mice gained slightly less weight 201 than WT mice over the course of the 17-week HFD, so that at the end of the study, HFD-ROCK2+/-202 mice weighed somewhat less than the corresponding WT mice, although both groups of mice were 203 much heavier than the corresponding normal chow fed mice (Table 1) . No significant differences in 204 fasting blood glucose between any of the groups were seen. However, the HFD-ROCK2+/-mice 205 exhibited improved insulin tolerance in an ITT compared to HFD-WT mice, since blood glucose levels 206 15 and 30 min after insulin administration in HFD-ROCK2+/-mice were not significantly different 207 from WT or ROCK2+/-mice fed normal chow and were significantly less than HFD-WT mice (Fig. 208 1A) . This difference was reflected in the AUC for glucose, which was significantly greater in HFD-WT 209 mice than in HFD-ROCK2+/-mice (Fig. 1B) . Serum cholesterol levels were also significantly 210 elevated in HFD-WT mice but not in HFD-ROCK2+/-mice compared to the corresponding normal 211 chow-fed groups (Table 1) . Serum non-esterified fatty acids (NEFA) in HFD-WT mice were not 212 significantly different from normal chow fed WT mice, but were significantly lower in HFD-ROCK2 213 +/-mice than in ROCK2+/-mice fed normal chow. However, there were no differences in either heart 214 weight or in cardiac triglyceride levels between any of the groups at termination (Table 1) . 215
Cardiac dimensions and function 216
Echocardiographic assessment of cardiac dimensions revealed that HFD-WT mice had a small but 217 significant increase in left ventricle mass compared to WT mice fed normal chow (Table 2) . In 218 addition, left ventricular end-diastolic internal diameter was significantly greater in the HFD-WT mice, 219 suggesting the onset of cardiac dilatation. In contrast, neither of these parameters was changed in HFD-220 ROCK2+/-mice compared to mice fed normal chow. High fat feeding had no significant effect on 221 either fractional shortening or ejection fraction in hearts from WT or ROCK2+/-mice (Table 2) . 222
However, the myocardial performance index (MPI), a sensitive measure of global left ventricular 223 function (42), was significantly increased in hearts from HFD-WT mice. This was related to an 224 increase in both the IVRT and the IVCT, measures of diastolic and systolic function, respectively, 225 indicating the emergence of cardiac contractile dysfunction in these animals. Both the IRVT and the 226 IVCT were normalized in hearts from HFD-ROCK2+/-mice, such that the MPI in these animals was 227 not significantly different from that in either WT or ROCK2+/-mice fed normal chow (Table 2) . 228
Speckle tracking-based strain echocardiography was used to determine whether there were regional 229 changes in left ventricular function in HFD mice. Left ventricular wall motion dyssynchrony was 230 apparent in HFD-WT mice ( Fig. 2A) . Analysis of endocardial wall motion demonstrated that 231 longitudinal forward and reverse velocity, strain and strain rate were all significantly decreased in 232 hearts from HFD-WT mice compared to WT mice fed normal chow (Fig. 2B-G) . These changes were 233 not seen in hearts from HFD-ROCK2+/-mice (Fig. 2) . No significant differences in radial wall motion 234 were detected in hearts from either genotype (Fig. 3) . 235
Obesity-induced impairment in cardiac contractile function has been found to be associated with 236 altered phosphorylation of troponin I (TnI) (35). Consistent with this, we found that the 237 phosphorylation of TnI Ser 23/24 was significantly reduced in hearts from HFD-WT mice (Fig. 4) . This 238 change was not seen in hearts from HFD-ROCK2+/-mice, in which phosphorylation of TnI was 239 significantly greater than in HFD-WT mice. This is consistent with the results of the contractile 240 function studies, and indicates that partial deletion of ROCK2 protects against the emergence of 241 obesity-induced cardiac dysfunction. 242
Effect of high fat feeding on the RhoA-ROCK pathway in the heart 243 We next investigated whether there were changes in RhoA-ROCK expression and/or activity in hearts 244 from HFD mice. Feeding WT mice a HFD for 17 weeks resulted in a significant increase in cardiac 245
RhoA and ROCK2 expression, but had no effect on the expression of ROCK1 (Fig. 5A-D) . However, 246 the activities of both ROCK1 and ROCK2 were significantly increased in hearts from HFD-WT mice 247 ( Fig. 5E and F) . As expected, the expression of ROCK2 was attenuated in hearts from ROCK2+/-mice 248 fed normal chow (Fig. 5D) ; this was accompanied by a decrease in ROCK2 activity of approximately 249 50% ( Fig. 5F ) but was not associated with any change in RhoA or ROCK1 expression or in ROCK1 250 activity (Fig. 5B,C and E) . In HFD-ROCK2+/-mice, ROCK2 expression tended to increase compared 251 to chow-fed ROCK2+/-mice, but levels remained well below those in hearts from WT mice and 252 ROCK2 activity was unchanged ( Fig. 5D and F) . Interestingly, the increase in RhoA expression found 253 in hearts from WT mice fed a HFD was not seen in HFD-ROCK2+/-mouse hearts (Fig. 5B) . 254
Furthermore, ROCK1 activity in HFD-ROCK2+/-mouse hearts further increased compared to HFD-255 WT mice (Fig. 5E) . 256
Cardiac insulin signaling and GLUT4 levels 257
Our next objective was to determine whether the elevated ROCK activity in hearts from HFD-WT mice 258 was associated with changes in the phosphorylation of IRS and in downstream cardiac insulin signaling 259 that were prevented in hearts from HFD-ROCK2+/-mice. The phosphorylation of IRS Tyr (Fig. 6A-C) . This 262 was associated with a decrease in the insulin-induced association of IRS with the p85 subunit of PI3K 263 in hearts from HFD-WT mice, accompanied by a decrease in the phosphorylation of Akt and its 264 downstream target AS160, all indicative of the development of impaired cardiac insulin signaling (Fig.  265 6D-F). These changes were completely prevented in hearts from HFD-ROCK2+/-mice (Fig. 6 ). There 266 were no significant differences in the phosphorylation of Tyr 612 or Ser 307 in IRS, in the association of 267 IRS with PI3K, or in the phosphorylation of Akt and AS160 in hearts from HFD-ROCK2+/-mice 268 compared to normal chow-fed WT or ROCK2+/-mice (Fig. 6) . In addition, the phosphorylation of IRS 269 Ser 632/635 was significantly reduced in hearts from HFD-ROCK2+/-mice compared to all other groups 270 (Fig. 6B) . 271
One of the characteristics of insulin resistance is a decrease in the expression of GLUT4 in insulin 272 sensitive organs (16). This was found in hearts from HFD-WT mice, in which GLUT4 levels were less 273 than 50% of levels in hearts from chow-fed WT-mice (Fig. 7A) . In contrast, GLUT4 levels in hearts 274 from HFD-ROCK2+/-mice were unchanged compared to levels in ROCK2+/-mice fed normal chow 275 (Fig. 7A) . Imaging of GLUT4 levels by confocal microscopy confirmed the higher expression of 276 GLUT4 in hearts from HFD-ROCK2+/-than from HFD-WT mice (Fig. 7B) . 277
PTEN activity 278
ROCK has been reported to increase the expression and activity of PTEN (phosphatase and tensin 279 homolog deleted on chromosome ten) in vascular cells, resulting in decreased activation of Akt (41). 280
Therefore we were interested to determine whether the beneficial effects of partial ROCK2 deletion on 281 cardiac insulin signaling could be due in part to reduced activation of PTEN. Although total PTEN 282 expression was unchanged in hearts from HFD-WT mice compared to mice fed normal chow (Fig. 8A) , 283 PTEN activity was markedly increased (Fig. 8B) . However, this increase was completely unaffected in 284 HFD-ROCK2+/-mice (Fig. 8B) , suggesting that increased activity of ROCK2 cannot be responsible 285 for the obesity-induced increase in PTEN activity. 286
287
TNFα expression 288
We previously reported that RhoA and ROCK activity were maintained in hearts from rats with type 1 289 streptozotocin (STZ)-induced diabetes by a positive feedback loop involving PKCβ 2 and iNOS (40). 290
However, no change in the expression or phosphorylation of PKCβ 2 (Fig. 9A ) or in iNOS expression 291 (Fig. 9B) was found in hearts from HFD-WT mice, suggesting that some other mechanism must be 292 responsible for the increased ROCK activity in these hearts. TNFα has been reported to increase ROCK 293 activity in a number of different cell types (4, 17), and we have found that the increased production of 294 inflammatory cytokines, including TNFα, is attenuated in adipose tissue from ROCK2+/-mice 295 (Soliman et al, unpublished) . Consistent with this, TNFα mRNA levels were reduced by approximately 296 40% in hearts from HFD-ROCK2+/-mice compared to hearts from HFD-WT mice (Fig. 9C) . 297
298
Discussion 299
The development of cardiac insulin resistance is a well-established consequence of chronic obesity in 300 both animal models and in humans, and is associated with changes in myocardial metabolism, 301 morphology and contractile function. The mechanisms contributing to obesity-induced cardiac insulin 302 resistance have been suggested to include defective insulin signaling due to altered phosphorylation of 303 IRS residues (22, 31). The results of the present study demonstrate that the decrease in cardiac insulin 304 signaling, GLUT4 expression and cardiac dysfunction resulting from feeding mice a HFD were 305 associated with a significant increase in myocardial ROCK1 and ROCK2 activity. Furthermore, partial 306 deletion of ROCK2 resulted in improvement in whole body insulin sensitivity and in normalization of 307 cardiac GLUT4 expression, insulin signaling and cardiac function in HFD mice. These data implicate 308 increased activity of ROCK2 in the development of cardiac insulin resistance and contractile 309 dysfunction associated with obesity. 310
How cardiac insulin resistance impacts cardiac function is not entirely clear but several mechanisms 311 have been proposed. Increased reliance of the insulin resistant heart on fatty acids for energy promotes 312 beta oxidation and increases generation of reactive oxygen species (2). Additionally, a mismatch 313 between the amount of fatty acids transported inside the cell and beta oxidation can result in 314 lipotoxicity and ceramide formation, resulting in increased apoptosis (32). Impaired insulin signaling 315 may also lead to mitochondrial dysfunction (8), dysregulated calcium cycling (11, 48), altered 316 cardiomyocyte size and remodeling (6, 15) and unrestrained autophagy (37). 317
The obesity-induced changes in cardiac morphology and function detected in HFD-WT mice in the 318 present study, while relatively subtle, are in good agreement with recent studies in human subjects (13, 319
46). Speckle tracking-based strain echocardiography is a relatively recently developed 320 echocardiographic technique that allows sensitive detection of early changes in regional ventricular 321 function, including wall motion and deformation (36). Early manifestations of left ventricular systolic 322
dysfunction, in particular subendocardial longitudinal fiber dysfunction leading to dyssynchrony, have 323 been detected by speckle tracking analysis in patients with obesity and the metabolic syndrome prior to 324 the development of overt systolic dysfunction (13, 42, 43) . Furthermore, an increase in the MPI, 325 indicating a deterioration of global cardiac performance, has also been documented in both obesity (19) 326 and in early stage type 2 diabetes (34) prior to the development of overt ventricular dysfunction. 327
Similarly, in the present study WT mice fed a HFD for 17 weeks did not manifest overt systolic 328 dysfunction, as assessed by lack of change in fractional shortening or ejection fraction. However, 329 speckle tracking analysis demonstrated the presence of significant endocardial longitudinal wall motion 330 abnormalities, suggesting the onset of systolic dysfunction, a finding supported by the increase in MPI 331 in these animals. All these changes in cardiac function were prevented in HFD-ROCK2+/-mice, 332
indicating that partial deletion of ROCK2 was able to prevent the onset of cardiac dysfunction due to 333 obesity. 334
The decrease in phosphorylation of Akt and AS160 in hearts from obese WT mice was accompanied by 335 an increase in the phosphorylation of Ser Reduced GLUT4 expression is characteristic of insulin resistance in the heart (24, 47) as well as in 346 other insulin-sensitive organs (16). It is detectable early after the onset of high fat feeding in hearts 347 from WT mice, and is associated with reduced glucose uptake even in the absence of impaired insulin 348 signaling (47). Consistent with the presence of cardiac insulin resistance, hearts from HFD-WT mice 349 had a marked reduction in GLUT4 expression that was not seen in hearts from HFD-ROCK2+/-mice. 350
These data suggest that both impaired cardiac insulin signaling and insulin resistance produced by high 351 fat feeding are mitigated in mice with partial deletion of ROCK2. 352
Because systemic insulin tolerance was improved and weight gain was slightly less in HFD-ROCK2+/-353 compared to HFD-WT mice, it is not clear whether the improvements in cardiac function, GLUT4 354 expression and insulin signaling in HFD-ROCK2+/-mice are due to a direct effect of preventing the 355 increase in ROCK2 activity in the heart, or whether they are secondary to an improvement in systemic 356 insulin sensitivity and reduction in obesity in these mice. A previous study in obese Zucker rats showed 357 that treatment with the non-isoform selective ROCK inhibitor fasudil not only normalized IRS Ser 307 358 phosphorylation in skeletal muscle, but improved systemic insulin sensitivity in association with a 359 decrease in adipose tissue TNFα levels (17). In the same study, stimulation of cultured C2C12 360 myotubes with TNFα produced an increase in ROCK activity and IRS Ser 307 phosphorylation that were 361 blocked by both fasudil and a second ROCK inhibitor Y27632 (17), implying a direct effect of elevated 362 ROCK activity to decrease insulin signaling in skeletal muscle. Interestingly, we found that TNFα 363 expression in hearts from HFD-ROCK2+/-mice was lower than that in HFD-WT mice, consistent with 364 our finding that the increase in adipose tissue TNFα in WT-HFD mice was attenuated in HFD-365 ROCK2+/-mice (Soliman et al, unpublished observations). However, whether increased TNFα 366 expression contributes to impaired insulin signaling through direct activation of ROCK2 in hearts from 367 HFD-WT mice remains to be confirmed. 368
No change in the phosphorylation of IRS-1 or downstream insulin signaling was detected in hearts 369 from ROCK2 +/-mice fed normal chow. This is in contrast to the results of previous studies of ROCK2 370 regulation of insulin signaling in cultured 3T3-L1 adipocytes and L6 myoblasts, in which ROCK2 371 siRNA altered the phosphorylation of IRS and/or it's downstream target Akt (10). This difference may 372 be an indication of the complex tissue and cell-specific regulation of insulin signaling by ROCK 373 isoforms that has been noted in previous studies (5, 10, 23, 30) . Alternatively, it is possible that the 374 residual ROCK2 protein levels in the ROCK2 +/-mice were sufficient to maintain normal IRS 375 phosphorylation, whereas levels achieved by ROCK2 siRNA in the cells were not. (PIP 2 ), thus reducing the PDK-1-mediated activation of Akt. Interestingly, in the present study PTEN 393 activity was markedly increased in hearts from both HFD-WT and HFD-ROCK2+/-mice. This 394 observation indicates that elevated ROCK2 activity cannot be responsible for the increased PTEN 395 activity induced by high fat feeding, although we cannot rule out a role for elevated ROCK1 activity in 396 this process. In addition, it suggests that PTEN activation contributes relatively little to the control of 397 Akt phosphorylation and insulin signaling in hearts from HFD mice, in contrast to the situation in 398 endothelial cells (41). 399
Interestingly, although the HFD-induced increase in both RhoA and ROCK2 expression and ROCK2 400 activity were abrogated, ROCK1 activity was further increased in HFD-ROCK2+/-compared to HFD-401 WT hearts. Although the reason for this is unknown, the data suggest that increased ROCK1 activity 402 cannot be responsible for the deterioration in cardiac function in HFD-WT mice. This is in contrast to 403 results obtained in two models of pathological cardiac hypertrophy, in which deletion of ROCK1 404 improved cardiac contractile function (39, 49) . 405
In summary, the results of the present study demonstrate that feeding mice a HFD results in increases 406 in the activity of both ROCK1 and ROCK2 in the heart. Partial deletion of ROCK2+/-prevents the 407 HFD-induced increase in ROCK2 but not ROCK1 activity in the heart, in association with improved 408 GLUT4 expression, insulin signaling and contractile function. These data implicate ROCK2 in the 409 development of obesity-induced insulin resistance and cardiac dysfunction, a finding that could have 410 important implications given the increasing incidence of obesity and its associated complications. 
